Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03312023
What this trial is testing

Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection

Who this might be right for
Hepatitis B
University of Maryland, Baltimore 21
Testing effectiveness (Phase 2)Study completedNCT01151423
What this trial is testing

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Ablynx, a Sanofi company 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT03787680
What this trial is testing

Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 49
Large-scale testing (Phase 3)UnknownNCT01402180
What this trial is testing

Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 128
Testing effectiveness (Phase 2)Study completedNCT00086879
What this trial is testing

Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07841496
What this trial is testing

ALT001 in Patients With Ischemic Stroke in the Sequelae Stage

Who this might be right for
Ischemic Stroke in the Sequelae Stage
Darwin Origin (Hubei) Biopharmaceutical Co., Ltd. 200
Testing effectiveness (Phase 2)Ended earlyNCT01646762
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Mayo Clinic 13
Testing effectiveness (Phase 2)Looking for participantsNCT07077746
What this trial is testing

HB-adMSCs for the Treatment of Crohn's Disease

Who this might be right for
Crohn Disease (CD)
Hope Biosciences Research Foundation 46
Testing effectiveness (Phase 2)Study completedNCT01795703
What this trial is testing

Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 47
Testing effectiveness (Phase 2)Looking for participantsNCT05254327
What this trial is testing

Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001

Who this might be right for
Rectal Cancer
University of Nebraska 118
Testing effectiveness (Phase 2)Study completedNCT00005027
What this trial is testing

Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT04620161
What this trial is testing

A Proof of Concept Study of Pradigastat in Patients With Functional Constipation

Who this might be right for
Functional Constipation
Anji Pharma 181
Testing effectiveness (Phase 2)Looking for participantsNCT06619561
What this trial is testing

Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Who this might be right for
Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC 48
Testing effectiveness (Phase 2)Study completedNCT00499486
What this trial is testing

Sirolimus in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 47
Testing effectiveness (Phase 2)Study completedNCT03304470
What this trial is testing

Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
UNION therapeutics 31
Testing effectiveness (Phase 2)UnknownNCT04542369
What this trial is testing

Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07649369
What this trial is testing

A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion

Who this might be right for
Malignant Pleural Effusions (Mpe)
Shanghai Jeyou Pharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT02102490
What this trial is testing

Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread

Who this might be right for
Metastatic Breast Cancer
Eli Lilly and Company 132
Testing effectiveness (Phase 2)WithdrawnNCT02371590
What this trial is testing

Lenalidomide and Obinutuzumab for Previously Untreated CLL

Who this might be right for
Chronic Lymphocytic Leukemia
University of California, San Diego
Testing effectiveness (Phase 2)Ended earlyNCT03705390
What this trial is testing

A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
University of Birmingham 11
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation